The Dash review and its impact on the future of patient advocacy
Concerns have been raised that NHS ten-year plan proposals may further complicate the patient safety and advocacy system, which Penny Dash has already dubbed a “cluttered landscape”.…
News
See all-
Pharmacists found to significantly reduce hospitalisations from heart failure
-
Almost half of pharmacy owners have used personal savings to subsidise NHS services
-
Diabetes medicines spend rises by almost 20% in one year
-
Pharmacists reduce wait for mental health medication reviews by average of five weeks
-
Government and APBI fail to reach agreement on cost of branded medicines
News from Wales
Why strong pharmacy leadership is essential for the NHS’s next decade
Royal Pharmaceutical Society Assembly meeting: 16 July 2025
Regulator plans policy overhaul on disqualification powers
Dale and Appelbe’s Pharmacy and Medicines Law: covering ‘essential ground in the most highly regulated areas of healthcare’
GPhC confirms 6% fee rise following consultation
NICE recommends weekly injection for severe haemophilia B
NICE rejects Alzheimer’s disease drugs for third time
News from Scotland
Why strong pharmacy leadership is essential for the NHS’s next decade
Royal Pharmaceutical Society Assembly meeting: 16 July 2025
Regulator plans policy overhaul on disqualification powers
Dale and Appelbe’s Pharmacy and Medicines Law: covering ‘essential ground in the most highly regulated areas of healthcare’
GPhC confirms 6% fee rise following consultation
NICE recommends weekly injection for severe haemophilia B
NICE rejects Alzheimer’s disease drugs for third time
Learning & CPD
Best practice for consultations with patients with additional speech and hearing needs
Urinary tract infection in adults: diagnosis, management and prevention
Frailty and the patient journey
Case-based learning: frailty
Polypharmacy and deprescribing in older people
Rheumatoid arthritis: management
Parenteral nutrition: indications and management
Haemato-oncology
Chronic lymphocytic leukaemia: diagnosis and management
Supported content
BRUKINSA is now reimbursed across the UK for R/R MZL
Promotional content
How can pharmacists best support patients with chronic lymphocytic leukaemia?
Supported content
Management of Waldenstrom’s macroglobulinaemia
Supported content
BTK inhibitors: what pharmacists need to know
Supported contentWant to see content related to your country or pharmacy sector on your homepage? Visit your preference centre to update your interests and help us improve your digital experience.
Newly registered?
Find our dedicated career advice and resources, clinical CPD and professional skills content here.
Research
See all-
Testosterone in menopause: a review of the evidence and prescribing practice
-
Advantages and disadvantages of shorter antimicrobial courses
-
Pharmaceuticals from marine sources: past, present and future
-
Improving the management of uncontrolled asthma for adults in England: where do pharmacists fit?
-
The role of community pharmacy in addressing health inequalities
-
Cannabidiol as a chemotherapy adjunct in cancer treatment